冠心病、房颤临床常用危险评分.pptVIP

ACS合并AF ACS患者房颤发病率10-21%，与年龄、梗死程度正相关； 加重缺血，诱发心衰，血栓栓塞； 房颤是ACS患者住院病死率 、30 d 病死率和1年病死率增加的独立预测指标； ACS合并AF长期抗栓策略 ACS合并AF抗栓推荐 Assess ischemic and bleeding risks using validated risk predictors (e.g., CHA2DS2-VASc, HAS-BLED) Keep triple therapy duration as short as possible; dual therapy only (oral anticoagulant and clopidogrel) may be considered in select patients Consider a target INR of 2.0–2.5 when warfarin is used Clopidogrel is the P2Y 12 inhibitor of choice Use low-dose (≤100 mg daily) aspirin PPIs should be used in patients with a history of gastrointestinal bleeding and are reasonable to